Clinical Trials

“Clinical trials are  the best way that APCaRI scientists can move new discoveries from the laboratory to the clinic.”

 

APCaRI is working in a new study to:

1. Find new tests in blood, urine, semen, or biopsy (or surgery) samples that can tell if a patient has prostate cancer.

2. Find tests that can identify aggressive cancers.

 

We need you!

Join the Study
Find Cancer Trials in Alberta

To discover these tests, blood, urine,  semen and clinical information from close to 4000 men are required. We plan to enroll patients over a period of 5 years in Calgary and Edmonton.

In Calgary, recruitment will occur at the Prostate Cancer Centre and Tom Baker Cancer Centre. In addition, participants may join the study by contacting the Calgary study coordinator at 403-943-8942.

In Edmonton, recruitment will occur at the Northern Alberta Urology Centre and Cross Cancer Institute. In addition, participants may join the study by contacting the Edmonton study coordinator at 780-407-5914.

Ask your doctor if you are eligible to participate in the study!

Submit your contact information to Participate

Download the Alberta Prostate Registry and Biorepository Information Brochure.

Download the Alberta Prostate Cancer Registry and Biorepository Information Brochure.

 

 

Clinical trials are one of the best ways to test new methods to diagnose, treat, manage, and prevent cancer, to ultimately deliver the best treatment and care possible to Albertans facing cancer.

Cancer Control Alberta reduces the impact of cancer on all Albertans and provides expert care and support for patients from their first symptom to survivorship. Supporting world-class research are two specialized teams that operate within the Clinical Trials Units at the Cross Cancer Institute and the Tom Baker Cancer Centre.  Each team provides well-trained staff and comprehensive services to researchers who are conducting clinical trials. In addition to the cancer centres, The Prostate Cancer Centre in Calgary and the Northern Alberta Urology Centre in Edmonton are testing advances in diagnosis and treatment to improve quality of life and work towards a cure for prostate cancer.

Find Clinical Trials in Alberta

New platform for prostate cancer diagnosis to be presented at ISEV 2017

The Lewis Research Group will present exciting results about new blood tests for prostate cancer during 3 talks at the upcoming 2017 International Society of Extracellular Vesicles (ISEV) annual meeting in Toronto (May 18-21). ISEV is a global society of researchers studying exosomes and microvesicles, which are the exciting new focus of cancer therapy and diagnosis.

Dr. Desmond Pink will speak about “Microflow cytometry: The Apogee A50 is a sensitive standard tool for extracellular vesicle analyses in liquid biopsies”, Robert Paproski’s presentation is entitled “Using machine learning of extracellular vesicle flow cytometry to build predictive fingerprints for prostate cancer diagnosis”, and Dr. John Lewis will speak about “An extracellular vesicle blood fingerprint distinguishes between patients with indolent and aggressive prostate cancer at diagnosis”.

The team is looking forward to sharing these key advances that were made possible through the APCaRI prospective cohort.

- John Lewis